Literature DB >> 18374358

Crystal structure of the C1 domain of cardiac myosin binding protein-C: implications for hypertrophic cardiomyopathy.

Lata Govada1, Liz Carpenter, Paula C A da Fonseca, John R Helliwell, Pierre Rizkallah, Emily Flashman, Naomi E Chayen, Charles Redwood, John M Squire.   

Abstract

C-protein is a major component of skeletal and cardiac muscle thick filaments. Mutations in the gene encoding cardiac C-protein [cardiac myosin binding protein-C (cMyBP-C)] are one of the principal causes of hypertrophic cardiomyopathy. cMyBP-C is a string of globular domains including eight immunoglobulin-like and three fibronectin-like domains termed C0-C10. It binds to myosin and titin, and probably to actin, and may have both a structural and a regulatory role in muscle function. To help to understand the pathology of the known mutations, we have solved the structure of the immunoglobulin-like C1 domain of MyBP-C by X-ray crystallography to a resolution of 1.55 A. Mutations associated with hypertrophic cardiomyopathy are clustered at one end towards the C-terminus, close to the important C1C2 linker, where they alter the structural integrity of this region and its interactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374358     DOI: 10.1016/j.jmb.2008.02.044

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

1.  Myosin binding protein C interaction with actin: characterization and mapping of the binding site.

Authors:  Inna N Rybakova; Marion L Greaser; Richard L Moss
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

2.  C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation.

Authors:  Samantha P Harris; Betty Belknap; Robert E Van Sciver; Howard D White; Vitold E Galkin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

3.  Top-down high-resolution mass spectrometry of cardiac myosin binding protein C revealed that truncation alters protein phosphorylation state.

Authors:  Ying Ge; Inna N Rybakova; Qingge Xu; Richard L Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-16       Impact factor: 11.205

Review 4.  Muscle myosin filaments: cores, crowns and couplings.

Authors:  John M Squire
Journal:  Biophys Rev       Date:  2009-09-11

5.  An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy.

Authors:  Poornima Gajendrarao; Navaneethakrishnan Krishnamoorthy; Senthil Selvaraj; Francesca Girolami; Franco Cecchi; Iacopo Olivotto; Magdi Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2015-05-14       Impact factor: 4.132

6.  The motif of human cardiac myosin-binding protein C is required for its Ca2+-dependent interaction with calmodulin.

Authors:  Yanling Lu; Ann H Kwan; Cy M Jeffries; J Mitchell Guss; Jill Trewhella
Journal:  J Biol Chem       Date:  2012-07-16       Impact factor: 5.157

Review 7.  Cardiac myosin binding protein-C: a structurally dynamic regulator of myocardial contractility.

Authors:  Natosha L Finley; Tzvia I Cuperman
Journal:  Pflugers Arch       Date:  2014-01-28       Impact factor: 3.657

8.  Phosphorylation and calcium antagonistically tune myosin-binding protein C's structure and function.

Authors:  Michael J Previs; Ji Young Mun; Arthur J Michalek; Samantha Beck Previs; James Gulick; Jeffrey Robbins; David M Warshaw; Roger Craig
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-23       Impact factor: 11.205

9.  N-Terminal Domains of Cardiac Myosin Binding Protein C Cooperatively Activate the Thin Filament.

Authors:  Cristina Risi; Betty Belknap; Eva Forgacs-Lonart; Samantha P Harris; Gunnar F Schröder; Howard D White; Vitold E Galkin
Journal:  Structure       Date:  2018-09-27       Impact factor: 5.006

10.  Determination of the phase diagram for soluble and membrane proteins.

Authors:  Sameer Talreja; Sarah L Perry; Sudipto Guha; Venkateswarlu Bhamidi; Charles F Zukoski; Paul J A Kenis
Journal:  J Phys Chem B       Date:  2010-04-08       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.